FAB Block vs. Placebo for Hip Arthroplasty Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorWomen's College Hospital

About this trial

Hip arthroplasty surgery can be associated with significant pain. A regional anesthesia technique, the femoral articular branch block (FAB), has recently been proposed to collectively block terminal femoral and accessory obturator nerve branches to the hip joint with a single injection, theoretically blocking most of the innervation relevant to hip arthroscopy while sparing the main femoral nerve branches to the quadriceps muscles. The investigators aim to demonstrate the analgesic benefits of FAB. The investigators hypothesize that FAB will reduce opioid consumption and improve postoperative quality of recovery in patients having hip arthroplasty. This is a randomized, controlled, double-blind study and half the patients will be randomized to receive the femoral articular branch block and the other half of patients will be randomized to receive a placebo block. A comparison of pain will be made between both groups.

Eligibility criteria

Qualifiers

ASA I-III patients

Ages 18-60yrs

BMI ≤ 35 kg/m2

Disqualifiers

Preexisting neurological deficits or peripheral neuropathy in the distribution of femoral, obturator, or lateral cutaneous nerves

Local infection

Contra-indication to regional anesthesia e.g. bleeding diathesis, coagulopathy

Chronic pain disorders

Trial design

Treatments tested in this trial

  • Femoral Articular Branch Block
  • Placebo Block

Treatment groups

95 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators